Photocure Partner Asieris to present first results for its Hexvix Phase III clinical trial in China at the SIU 2023 Annual Meeting

Press Release - Oslo, Norway, October 7, 2023: Photocure ASA , the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals has communicated its plan today to unveil the first...

Related Keywords

Turkey ,Norway ,Istanbul ,Oslo ,Chile ,United States ,China ,Australia ,New Zealand ,Taiwan ,Canada ,Israel ,Chinese ,American ,Dan Schneider ,David Moskowitz ,Cysview Hexvix ,Hexvix Cysview ,Erik Dahl ,Asieris Pharmaceuticals ,Corporate Communications ,Oslo Stock Exchange ,Bladder Cancer Company ,American Cancer Society ,Press Release ,Cancer Company ,Blue Light Cystoscopy ,Stock Exchange ,Markets ,